Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood
Condition(s):Systemic Lupus ErythematosusLast Updated:May 12, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Systemic Lupus ErythematosusLast Updated:May 12, 2015Completed
Condition(s):LymphomaLast Updated:October 9, 2019Completed
Condition(s):LymphomaLast Updated:July 6, 2016Completed
Condition(s):Recurrent Childhood Acute Lymphoblastic LeukemiaLast Updated:December 12, 2017Completed
Condition(s):LeukemiaLast Updated:November 6, 2017Completed
Condition(s):Leukemia; Pediatric CancerLast Updated:May 22, 2014Terminated
Condition(s):Recurrent or Refractory B Cell Acute Lymphoblastic LeukaemiaLast Updated:July 14, 2014Unknown status
Condition(s):Leukemia; LymphomaLast Updated:June 22, 2011Completed
Condition(s):LymphomaLast Updated:August 16, 2021Unknown status
Condition(s):LymphomaLast Updated:August 16, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.